Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: AbbVie | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: AbbVie

HUMIRA sales up 14% to $4.7 billion in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie
1Q Revenues: $7.9 billion (+21%)
1Q Earnings: $2.8 billion (+63%)
Comments: Global HUMIRA sales were $4.7 billion, up 14%. IMBRUVICA sales were $762 million, up 39%. Global HCV sales were $919 million in the quarter, up more than 100%. Synagis
sales were up 7% to $321 million. Duodopa sales were up 17% to $103 million. Kaletra sales continued to decline to $73 million, down 39% in the quarter.
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters